Transaction · 0001225208-26-004909

Lippis Daniel J.

Lippis Daniel J., CVP, TAVR, reported an open-market or private sale at Edwards Lifesciences Corp involving 1000.000000 shares for an estimated $82988.90. Reported holdings after the transaction were 33933.910300 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCVP, TAVR
EWEdwards Lifesciences Corp
Trade date
May 01, 2026
Filing date
May 04, 2026
View on SEC Insider profile
Disclosed value-$82.9kShares × reported price
Shares traded1.00k$82.99 per share
Holdings after33.9kDirect
% of reported position traded2.86%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 34,933.9103 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

EW price since this filing

Daily closing prices, with the filing date and available return windows
EW · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -3.2%1w ago -3.2%1d ago -3.2%
Returns since7d +0.0%30d +5.0%90d +2.5%180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001225208-26-004909
Common Stock
Transaction date
May 01, 2026
Filed May 04, 2026, 11:30 PM · 3d delay
Shares
1,000 sh
$82.99 per share
Estimated value
-$82.9k
Computed from shares × price
Holdings after
33,933.9103 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Sale 10b5-1 Detected
Filing-only score

-4 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CVP, TAVR

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 30, 2025.

  2. F2

    This transaction was executed in multiple trades at prices ranging from $83.980 to $84.095. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to…

  3. F3

    This transaction was executed in multiple trades at prices ranging from $82.540 to $83.490. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to…

Original filing · 0001225208-26-004909
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

EW